FLUOROPASSIV Trademark

Trademark Overview


On Thursday, March 31, 2016, a trademark application was filed for FLUOROPASSIV with the United States Patent and Trademark Office. The USPTO has given the FLUOROPASSIV trademark a serial number of 79189100. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 18, 2023. This trademark is owned by Vascutek Limited. The FLUOROPASSIV trademark is filed in the Medical Instrument Products category with the following description:

Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stents, vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prost...
fluoropassiv

General Information


Serial Number79189100
Word MarkFLUOROPASSIV
Filing DateThursday, March 31, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 18, 2023
Registration Number5135131
Registration DateTuesday, February 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements


Translation of Words in MarkThe wording "FLUOROPASSIV" has no meaning.
Goods and ServicesSurgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stents, vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, and vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devices, namely, aneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, surgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; thin wall carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 18, 2023
Primary Code010
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameVascutek Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRenfrewshire PA4 9RR, GB

Party NameVascutek Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRenfrewshire PA4 9RR, GB

Party NameVascutek Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRenfrewshire PA4 9RR, GB

Trademark Events


Event DateEvent Description
Friday, August 5, 2016REFUSAL PROCESSED BY IB
Thursday, July 14, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 15, 2016ASSIGNED TO EXAMINER
Tuesday, July 19, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, July 19, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 20, 2016REFUSAL PROCESSED BY MPU
Wednesday, July 20, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017REGISTERED-PRINCIPAL REGISTER
Sunday, May 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, June 3, 2017FINAL DISPOSITION PROCESSED
Thursday, September 8, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 17, 2016ASSIGNED TO LIE
Thursday, September 22, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 17, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, June 3, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 18, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, June 24, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 18, 2023CANCELLED SECTION 71